Irinotecan- vs. Oxaliplatin-Based Doublets in KRAS(G12C)-Mutated Metastatic Colorectal Cancer—A Multicentre Propensity-Score-Matched Retrospective Analysis

SIMPLE SUMMARY: The sensitivity to chemotherapy of KRASG12C-mutated colorectal cancer has been investigated to verify whether the combination of chemotherapy plus a KRASG12C-inhibitor might become the standard of care in the near future. To this aim, the present retrospective study was designed to a...

Descripción completa

Detalles Bibliográficos
Autores principales: Formica, Vincenzo, Morelli, Cristina, Conca, Veronica, Calegari, Maria Alessandra, Lucchetti, Jessica, Dell’Aquila, Emanuela, Schirripa, Marta, Messina, Marco, Salvatore, Lisa, Lo Prinzi, Federica, Dima, Giovanni, Trovato, Giovanni, Riondino, Silvia, Roselli, Mario, Skoulidis, Ferdinandos, Arkenau, Hendrik-Tobias, Cremolini, Chiara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10252545/
https://www.ncbi.nlm.nih.gov/pubmed/37297026
http://dx.doi.org/10.3390/cancers15113064

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10252545/
https://www.ncbi.nlm.nih.gov/pubmed/37297026
http://dx.doi.org/10.3390/cancers15113064

Ejemplares similares